Changing R&D models in research-based pharmaceutical companies
نویسندگان
چکیده
منابع مشابه
Regulation of Clinical Research Sponsored by Pharmaceutical Companies: A Proposal
D rug development is indispensable to deal effectively with disease [1]. However, two dilemmas emerge from clinical research devoted to this goal. First, new drugs are the source of a huge economy ruled not by the standards of the medical profession, but by the rules of business and the market [2]. Second, although the testing and the medical community's " blessing " of a new drug lie entirely ...
متن کاملChanging models of biomedical research.
Thanks to the revolutions in information technology, human "-omics" research, and intricate medical device development, academic health centers (AHCs) now have an unparalleled potential to become translational engines that both generate basic science advances and then translate them into human studies and, ultimately, into improved health care. However, AHC infrastructures have traditionally be...
متن کاملVirtual pharmaceutical companies: collaborating flexibly in pharmaceutical development.
Research and development (R&D) collaborations represent one approach chosen by the pharmaceutical industry to tackle current challenges posed by declining internal R&D success rates and fading of the blockbuster model. In recent years, a flexible concept to collaborate in R&D has emerged: virtual pharmaceutical companies (VPCs). These differ from other R&D companies, such as biotech start-ups, ...
متن کاملMultinational pharmaceutical companies gather in Berlin.
The 39th Annual General Meeting of the Pharma Documentation Ring (PDR) was held in Berlin, Germany, on September 26, 1997. Common themes reported on included the impact and widespread use of intranet technology; expansion in end-user searching; experience with electronic journals; and programs for the development of electronic archiving and document management systems. Other sessions discussed ...
متن کاملBuyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern
healthcare and Ranbaxy have been bought by Abbott and Daiichi Sankyo, respectively.[3] Cipla, an indigenous company, lone with a market share of about 5.4% tops the list of top 10 companies in India. The increasing presence of foreign companies among the top pharmaceutical companies in India is may be due to a few buyouts which happened in the recent past. Daiichi Sankyo, a leading Japanese pha...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Translational Medicine
سال: 2016
ISSN: 1479-5876
DOI: 10.1186/s12967-016-0838-4